Guangdong VTR Bio-Tech Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Derong Zhou
Chief executive officer
CN¥922.7k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2.3yrs |
| CEO ownership | 0.3% |
| Management average tenure | no data |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
Guangdong VTR Bio-Tech Co., Ltd. (SZSE:300381) Looks Inexpensive But Perhaps Not Attractive Enough
Sep 30
Guangdong VTR Bio-Tech's (SZSE:300381) Soft Earnings Are Actually Better Than They Appear
May 02There's No Escaping Guangdong VTR Bio-Tech Co., Ltd.'s (SZSE:300381) Muted Revenues Despite A 35% Share Price Rise
Apr 30Guangdong VTR Bio-Tech Co., Ltd.'s (SZSE:300381) Share Price Boosted 28% But Its Business Prospects Need A Lift Too
Mar 08CEO
Derong Zhou (56 yo)
2.3yrs
Tenure
CN¥922,700
Compensation
Mr. Derong Zhou is President of Guangdong VTR Bio-Tech Co., Ltd. from August 26, 2022. He joined the Guangdong VTR Bio-Tech Co., Ltd.on November 17, 2017. He was Executive VP & Board Secretary of Guangdon...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Director | 7.1yrs | CN¥922.70k | 0.26% CN¥ 9.1m | |
| Supervisor & Accounting Supervisor | 10.2yrs | no data | no data | |
| Non-Employee Supervisor | 11.5yrs | no data | no data | |
| Chairman | 7.1yrs | CN¥1.20m | no data | |
| Independent Director | less than a year | no data | no data | |
| Non Independent Director | 3.8yrs | CN¥80.00k | no data | |
| Non Independent Director | 3.8yrs | CN¥270.40k | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data |
3.8yrs
Average Tenure
54yo
Average Age
Experienced Board: 300381's board of directors are considered experienced (3.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 02:01 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Guangdong VTR Bio-Tech Co., Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jia Chen | Changjiang Securities Co. LTD. |
| Xiao Bao Liu | Everbright Securities Co. Ltd. |
| Baoping Zhang | Founder Securities Co., Ltd. |